Journal article
Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline
Abstract
BACKGROUND: This study aims to provide guidance for the use of neoadjuvant and adjuvant systemic therapy in women with newly diagnosed stage II-IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma.
METHODS: EMBASE, MEDLINE, and Cochrane Library were investigated for relevant systematic reviews and phase III trials. Articles focusing on consolidation and maintenance therapies were excluded.
Authors
Hirte H; Poon R; Yao X; May T; Ethier J-L; Petz L; Speakman J; Elit L
Journal
Current Oncology, Vol. 29, No. 1, pp. 231–242
Publisher
MDPI
DOI
10.3390/curroncol29010022
ISSN
1198-0052